Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Update your website incompetents

<< Previous

Bullboard Posts

Next >>

Comment by Lee430on Jun 07, 2022 12:21pm

63 Views

Post# 34737300

RE:RE:RE:Update your website incompetents

Agreed.

palinc2000 wrote: I think she has other prioritiesand we might soon see another version of the website but I think she is not the one to blame for the lack of housekeeping .....The CFO should have made the change ......

Lee430 wrote: Frustrating! I had sent Dubuc an email requesting they update the contact info after our old IR director had left, her phone # was inactive and another company already sent out a PR announcing the hire of our old IR director...Sooo here we are again, how does this happen?

Biobob wrote: They announced a new IR person on May 31.. we are June 7 and it is still Dubuc listed as IR contect on the website.... it takes 3 miutes to make that change... it's coumpouded incompetence in the end...